» Articles » PMID: 24661628

Diabetic Gastrointestinal Motility Disorders and the Role of Enteric Nervous System: Current Status and Future Directions

Overview
Date 2014 Mar 26
PMID 24661628
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gastrointestinal manifestations of diabetes are common and a source of significant discomfort and disability. Diabetes affects almost every part of gastrointestinal tract from the esophagus to the rectum and causes a variety of symptoms including heartburn, nausea, vomiting, abdominal pain, diarrhea and constipation. Understanding the underlying mechanisms of diabetic gastroenteropathy is important to guide development of therapies for this common problem. Over recent years, the data regarding the pathophysiology of diabetic gastroenteropathy is expanding. In addition to autonomic neuropathy causing gastrointestinal disturbances the role of enteric nervous system is becoming more evident.

Purpose: In this review, we summarize the reported alterations in enteric nervous system including enteric neurons, interstitial cells of Cajal and neurotransmission in diabetic animal models and patients. We also review the possible underlying mechanisms of these alterations, with focus on oxidative stress, growth factors and diabetes induced changes in gastrointestinal smooth muscle. Finally, we will discuss recent advances and potential areas for future research related to diabetes and the ENS such as gut microbiota, micro-RNAs and changes in the microvasculature and endothelial dysfunction.

Citing Articles

Prevalence of gastroparesis symptoms and its associated factors among type 2 diabetes mellitus patients in West Bank in Palestine: a national cross-sectional study.

Asad D, Zreqat Q, Idais S, Hussein B, Ayyad A, Hunjul M Front Med (Lausanne). 2025; 12:1499725.

PMID: 40012984 PMC: 11862999. DOI: 10.3389/fmed.2025.1499725.


The Abnormal Expression of Tubular SGLT2 and GULT2 in Diabetes Model Mice with Malocclusion-Induced Hyperglycemia.

Kajiwara K, Tamaoki S, Sawa Y Biomedicines. 2025; 13(2).

PMID: 40002681 PMC: 11853642. DOI: 10.3390/biomedicines13020267.


A Comprehensive Review of the Effects of Diabetes Mellitus on the Gastrointestinal System.

Sattaru K, Thipani Madhu M, Kumar Singh J, Kandi V, Gupta A, Ca J Cureus. 2025; 17(1):e77845.

PMID: 39991373 PMC: 11845257. DOI: 10.7759/cureus.77845.


A bibliometric analysis of diabetic gastroparesis from 1979 to 2024.

Xu H, Miao F, Fan Y Front Med (Lausanne). 2024; 11:1445276.

PMID: 39450111 PMC: 11500038. DOI: 10.3389/fmed.2024.1445276.


Beneficial effects of resveratrol on diabetes mellitus and its complications: focus on mechanisms of action.

Ahmadzadeh A, Aliabadi M, Mirheidari S, Hamedi-Asil M, Garousi S, Mottahedi M Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39446148 DOI: 10.1007/s00210-024-03527-4.


References
1.
Ward S, Beckett E, Wang X, Baker F, Khoyi M, Sanders K . Interstitial cells of Cajal mediate cholinergic neurotransmission from enteric motor neurons. J Neurosci. 2000; 20(4):1393-403. PMC: 6772355. View

2.
Surendran S . Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility. Mol Biol Rep. 2007; 36(1):201-6. DOI: 10.1007/s11033-007-9167-2. View

3.
Islam M . Animal models of diabetic neuropathy: progress since 1960s. J Diabetes Res. 2013; 2013:149452. PMC: 3745837. DOI: 10.1155/2013/149452. View

4.
Maeda H, Yamagata A, Yoshinaga K, Kobayashi S, Nishi K, Nishikawa S . Requirement of c-kit for development of intestinal pacemaker system. Development. 1992; 116(2):369-75. DOI: 10.1242/dev.116.2.369. View

5.
Sanders K, Koh S, Ward S . Interstitial cells of cajal as pacemakers in the gastrointestinal tract. Annu Rev Physiol. 2006; 68:307-43. DOI: 10.1146/annurev.physiol.68.040504.094718. View